BIOGAS — Biokraft International AB Income Statement
0.000.00%
Last trade - 00:00
- SEK871.58m
- SEK1.64bn
- SEK445.83m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 364 | 338 | 394 | 367 | 446 |
Cost of Revenue | |||||
Gross Profit | 183 | 158 | 220 | 181 | 190 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 365 | 344 | 389 | 432 | 519 |
Operating Profit | -1.94 | -6.04 | 4.99 | -65.2 | -73.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -63.2 | -64.5 | -45.5 | -95.4 | -172 |
Provision for Income Taxes | |||||
Net Income After Taxes | -55.9 | -63.2 | -38.7 | -84.9 | -159 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -42.5 | -56.8 | -34.1 | -81.9 | -160 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -42.5 | -56.8 | -34.1 | -81.9 | -160 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.4 | -1.51 | -1.03 | -1.95 | -3.65 |
Dividends per Share |